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The Chediak-Higashi Syndrome (CHS)' is a genetic disease that occurs in the
human (1), cow (2), cat (3), mink (4), and mouse (5). In the mouse, the recessive
beige gene is located on the proximal end of chromosome 13 (5). Homozygous
beige mice exhibit most of the phenotypic characteristics of human Chediak-
Higashi patients (5).
One of the more striking quantitative observations of CHS is the very large
decrease in neutral proteinase activity of circulating leukocytes and peritoneal
neutrophils. In humans, Vassalli et al. (6) found a virtual absence of neutral
proteinase activity in circulating leukocytes of three CHS patients. We found
that the similar neutral proteinase deficiency in peritoneal neutrophils of the
beige mouse is due to a profound decrease of both elastase and cathepsin G (7).
This is true for peritoneal neutrophils of four independent beige mutants and
could explain the increased susceptibility to infection ofbeige mice and Chediak-
Higashi patients (8, 9).
As is well known, neutrophils-undergo progressive development and differ-
entiation in bonemarrow from theprimitive myeloblast before becomingmature
neutrophils (10, 11). Mature neutrophils are stored in bone marrow before
release into the circulation (10). Lysosomal enzyme(s), presumably including
lysosomal elastase and cathepsin G, are synthesized relatively early, that is, in the
promyelocyte or early myelocyte stage (10, 12).
We present evidence thatprecursor neutrophils ofbone marrow ofbeige mice
have considerable neutral proteinase (elastase and cathepsin G) activity. Mature
marrow neutrophils, in contrast, have greatly decreased neutral proteinase
activity. Also, blood neutrophils ofbeige mice have a virtual absence of elastase
and cathepsin G activities. This result indicates that the major mechanism for
the lowered neutrophil elastase and cathepsin G activities in mature neutrophils
of beige mice is not due to an absence of enzyme synthesis, but rather, it is
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caused by a novel loss of the activities of these enzymes during neutrophil
maturation in bone marrow .
Materials and Methods
The following materials were obtained from the indicated sources : Hanks' Ca"- and
Mg"-free balanced saline solution (HBSS ; Gibco Laboratories, Grand Island, NY) ; Ficoll-
Paque (Pharmacia Fine Chemicals, Uppsala, Sweden) ; methoxysuccinyl-alanyl-alanyl-pro-
lyl-valine-4-methylcoumarinyl-7-amide (MeO-Suc-Ala-Ala-Pro-Val-MCA), t-Boc-valyl-gly-
cyl-arginine-4-methylcoumarinyl-7-amide (t-Boc-Val-Gly-Arg-MCA), and amino methyl
coumarin (AMC) were purchased from Vega Biotechnologies, Inc ., Tucson, AZ ; Z-glycyl-
leucyl-phenylalanine chloromethyl ketone (Z-Gly-Leu-Phe-CH 2Cl), and methoxysuccinyl-
alanyl-alanyl-prolyl-valine chloromethyl ketone (MeO-Suc-Ala-Ala-Pro-Val-CH2C1) from
Enzyme Systems Products, Livermore, CA ; succinyl-alanyl-alanyl-prolyl-phenylalanine p-
nitroanilide (Suc-Ala-Ala-Pro-Phe-pNA), succinyl-glycyl-prolyl-leucyl-glycyi-proiine-4-
methylcoumarinyl-7-amide (Suc-Gly-Pro-Leu-Gly-Pro-MCA), PMSF, N-ethylmaleimide,
DMSO, p-chloromercuribenzoate, soybean trypsin inhibitor, a,-antitrypsin, aprotinin,
elastin-orcein, naphthol AS-D chloroacetate, and fast garnet GBC from Sigma Chemical
Co ., St . Louis, MO . All other reagents were ofanalytical grade .
Animals.
￿
C57BL/6J (+/+) and C57BL/6J beige (bgJ/bgJ) male and female mice were
originally purchased from The Jackson Laboratories (Bar Harbor, ME) and were subse-
quently bred at the animal facilities of Roswell Park Memorial Institute .
Preparation ofBone Marrow Cells.
￿
Bone marrow was prepared according to the method
of Watt et al . (13) with the following modification . Femoral shafts were removed from
hind legs and marrow plugs flushed with 1-2 ml ofHBSS containing 5 mM EDTA (HBSS-
EDTA) using a 25-gauge needle . The cells were gently suspended, centrifuged, and
washed once in HBSS-EDTA at 4°C . Red cells were lysed by suspending the cell pellet in
10 ml of 0.168 M NH4Cl for 5 min at room temperature . The cells were washed three
times with HBSS-EDTA . Differential counts were performed on an aliquot of the final
washed cells by light microscopy after Stat-staining (VWR Scientific Inc ., San Francisco,
CA) . The remaining cells were resuspended with cold 0.2% Triton X-100, 0.2 M sucrose,
0.15 M NaCl, 5 mM EDTA in 20mM imidazole-HCI, pH 7.4 and extracted according to
the methods described elsewhere (7) . The homogenate was centrifuged at 13,000 g for
10 min at 4 ° C, and the supernatant was used as a source of elastase and/or cathepsin G .
Isolation of Mature Neutrophils From Peripheral Blood .
￿
Blood was drawn by cardiac
puncture with a 22-gauge needle attached to a 1-ml plastic syringe that contained 0.1 ml
of 3.8% sodium-citrate (14). Each milliliter of blood was mixed with 5 ml ofHBSS-EDTA
containing dextran to make a 2% (wt/vol) final dextran concentration . The mixture was
gently shaken for 10 s and left for 45 min at room temperature .
The leukocyte-rich supernatant and buffy coat were carefully harvested, and platelets
were separated with the supernatant after centrifugation at 200 g for 5 min at 15 °C . The
pellet was suspended in HBSS-EDTA and underlaid with Ficoll-Paque for further purifi-
cation of neutrophils (7) . Lymphocytes, monocytes, and platelets from the interface were
withdrawn and discarded, whereas neutrophils from the pellet were collected . The pellet
was washed once with HBSS-EDTA and the contaminating red cells were removed by a
0.168 M NH 4Ci . The cells were washed three times with HBSS-EDTA . An aliquot o£
final washed cells was examined by light microscopy after Stat staining . Extracts of cells
were prepared as described previously (7) .
InductionandPreparation ofElicited Peritoneal Neutrophils.
￿
Peritoneal neutrophils were
elicited by the copper-rod implantation technique originally described by McGarry (15) .
Harvest and purification of peritoneal neutrophils were described previously (7).
Enzyme Assays.
￿
Elastase activity was measured with the fluorogenic substrate MeO-
Suc-Ala-Ala-Pro-Val-MCA as described by Takeuchi et al. (7). I U of elastase activity is
defined as the formation of 1 nmol of AMC per minute . The protein substrate, elastin-
orcein, was also applied to examine elastase hydrolytic activity (16) . 6 mg/ml elastin-orcein
was incubated with extracts at 37 *C . The change ofabsorbanceat 570 nm was determined .1364
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TABLE I
Activities ofElastase and Cathepsin G in Bone Marrow Extracts ofNormal
Heterozygous (+/bgJ), and Beige (bgJ/bgJ)Mice
Results
Bone marrow cells were extracted as described in MaterialsandMethods. Elastase was assayed with
the substrate MeO-Suc-Ala-Ala-Pro-Val-MCA. 1 U of elastase activity corresponds to the release
of 1 nmol of product per minute . Cathepsin G activity is expressed as AE/min at 410 nm (x 10 s).
Specific activities are expressed as mean ± SEM of assays of number of individual mice in
parentheses . No significant difference in enzyme activity wasfoundbetween male and female mice.
* P :5 0.001
t p <- 0.005
Cathepsin G wasassayed using Suc-Ala-Ala-Pro-Phe-pNA as substrate as described previ-
ously (7) . Cathepsin G activity is expressed as DE/min at 410 nm (x 10') at 50°C. Other
enzyme assays and inhibition studies were performed as described by Takeuchi et al . (7) .
Enzyme Histochemistry ofBoneMarrow Neutrophils .
￿
Thecombined elastase and cathepsin
G activities in neutrophils were examined histochemically using naphthol AS-D chloroac-
etate as substrate (17) . Bone marrow smears were air dried and fixed in 10% formalin/90%
McOH for 30 s at 0'C . They were subsequently rinsed with distilledwater for 5 min and
air dried . The fixed smears were stained for enzyme activity for 30 min according to the
method of Moloney et al . (17) . The number of neutrophils of each of five precursor
classes (myeloblasts, promyelocytes, myelocytes, metamyelocytes, and PMNs) were enum-
erated and intensity of enzyme stain was independently estimated for each cell on a 0 to
4+ scale by two observers . Some smears were also preincubated with 0.2 mM McO-Suc-
Ala-Ala-Pro-Val-CH 2Cl (neutrophil elastase inhibitor) or 0.2 mM Z-Gly-Leu-Phe-CH 2C1
(cathepsin G inhibitor) or both inhibitors, before examination .
BoneMarrow ElastaseandCathepsin Gin NormalandBeigeMice.
￿
To investigate
whether elastase and cathepsin G in neutrophils from beige mice are missing at
all levels of neutrophil maturation, neutrophil elastase activity, assayed with the
specific and sensitive fluorogenic substrate MeO-S.uc-Ala-Ala-Pro-Val-MCA (18-
20), and cathepsin G, assayed with Suc-Ala-Ala-Pro-Phe-pNA, were determined
in cell suspensions ofbone marrow from normal and beige mice (Table 1) .
Unlike the previously described (7) near absence in beige mice of elastase and
cathepsinG in peritoneal neutrophils, bone marrow maintained>58% of normal
bone marrow elastase activity per neutrophil (Table 1) . Similarly, beige marrow
had >57% normal cathepsin G levels . Heterozygotes produced from a cross
between normal and beige mice had normal levels of elastase and cathepsin G
activities (Table 1) . These combined results indicate that two copies of the beige
gene are necessary for production of the lowered enzyme levels . No significant
differences were foundamong the three types of mice in total marrow cellularity
or total marrow neutrophils.
The bone marrow and elicited peritoneal neutrophil extracts of normal and
Genotype n Total cells per
Femur
x10-6
Neutrophils
9C ,
Elastase
Units per
x10'
Cathepsin
neutrophil
G
C57BL/6J (+/+) 5 14.03 t 1 .84 49.3 t 2 .3 4.35 ± 0.17 (5) 5.01 ± 0.18 (5)
C57BL/6J (+/bgJ) 4 12.29± 3.95 51 .7 ± 3 .1 5.0 ± 0.11 (4) 5.19 ± 0.15 (3)
C57BL/6J (bgJ/bgJ) 6 13.78± 0.74 51 .8 ± 1 .8 2.54 ± 0.14 (6)* 2.90 t 0.31 (4)$TAKEUCHI ET AL .
￿
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TABLE II
Activity ofElastase in Bone Marrow and Elicited Peritoneal
Neutrophils as Measured by Hydrolysis ofElastin
Genotype
￿
Bone marrow
￿
Peritoneal neutrophil
C57BL/6J (+/+)
￿
0.181 ± 0.003 (3)
￿
0.194 ± 0.008 (3)
C57BL/6J (bgJ/bgJ)
￿
0.126 ± 0.005 (3)*
￿
0.038 ± 0.007 (3)*
Bone marrow cells were extracted as described in Methods . Peritoneal
neutrophils were elicited by acopper-rod implantation described previ-
ously (7). Elastase was assayed with the substrate elastin-orcein . The
elastolytic activity is expressed as DE/h/mg protein at 570 nm. Specific
activity is expressedas mean ±SEMofassays ofthe number ofindividual
mice in parentheses.
* P :5 0.001
beige mice were also examined for their elastolytic activity against a second
elastase substrate, elastin-orcein . Beige bone marrow had nearly 70% of normal
bone marrow elastolytic activity (Table II) . Extracts of elicited peritoneal neutro-
phils of beige mice, however, had <20% normal elastolytic activity (Table II) .
Thus the two elastase assays gave similar results although the residual elastase
activity in beige peritoneal neutrophils is lower (7) with the synthetic substrate,
MeO-Suc-Ala-Ala-Pro-Val-MCA .
Evidence that Bone Marrow Elastase Is Found in Neutrophils.
￿
Since bone mar-
row is composed of a heterogeneous cell population, it was uncertain if the
measured elastase activity was predominantly in neutrophils and neutrophil
precursor cells . A direct test would be to analyze purified bone marrow neutro-
phils . However, it is presently not possible to isolate pure neutrophils from
marrow . We have therefore used a histochemical test plus two indirect tests to
determine the cellular location of marrow elastase .
In the first test, the localization of elastase in bone marrow was examined by
an enzyme histochemical technique using naphthol AS-D chloroacetate as sub-
strate (17) . The naphthol AS-D ohloroacetate esterase reaction is performed as
an azo-coupling sequence with fast garnet GBC . As seen in Fig. la, normal
neutrophils exhibit a strong hydrolytic activity toward this substrate . The activity
evident as reddish brown aggregates was found only in neutrophils or neutrophil
precursors (Fig . 1, a and b) . Eosinophils and basophils (not shown), along with
monocytes, lymphocytes, and megakaryocytes (Fig. 2), did not demonstrate
enzyme activity with this substrate in agreement with the original report of
Moloney et al . (17) .A very noticeable difference in staining patternswas apparent
between beige neutrophils in which reaction product was deposited in giant
granules (Fig . 1 b) and normal neutrophils in which reaction product was dis-
persed in very small granules (Fig . 1 a) . The enzyme activity in normal and beige
bone marrow was characterized by its elimination with the specific inhibitors
MeO-Suc-Ala-Ala-Pro-Val-CH 2C1 for neutrophil elastase and Z-Gly-Leu-Phe-
CH2Cl for cathepsin G . Pretreatment of bone marrow smears with either chlo-
romethyl ketone inhibitor caused a greatly, though not completely, diminished
activity in neutrophils of normal and beige marrows . However, bone marrow
smears pretreated with both inhibitors had no activity (Fig . 1, c and d) . These1366
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FIGURE 2 .
￿
Neutral proteinase activity staining is specific for neutrophils . Beige marrow cells
were histochemically stained for neutral proteinase as described in Fig. 1 . (a) Megakaryocyte
(Mg) has no detectable activity. In the original slides it is apparent that the black "dots"
apparent within the megakaryocyte nucleus are not the true reddish-brown reaction product
of the neutral proteinase substrate. Adjacent myelocytes (M) and metamyelocytes (Mm) have
obvious reaction product in giant lysosomes (arrows) . Lymphocytes (b)and monocytes (c) have
no visible reaction products . x 2,000 .
results indicate that the histochemical enzyme activity represents a combination
of both elastase and cathepsin G activities in bone marrow neutrophils .
In the second test, the proportion ofneutrophils in bonemarrow was perturbed
and then marrow elastase-specific activitywas tested for a corresponding change .
Implantation of a copper-rod into the mouse peritoneal cavity resulted in a
significant increase in neutrophils of bone marrow (Table III) . Corresponding
to the increase in the number of mature neutrophils was an increase in the
specific activity of elastase (U/mg protein) in bone marrow ofnormal mice 3 and
6 d after copper-rod implantation (Table III) . In beige bone marrow, on the
FIGURE 1 .
￿
Neutral proteinase activity of normal and beige bone marrow . (a) Normal bone
marrow . Marrow cells were stained for neutral proteinase activity with naphthol AS-D
chloroacetate as substrate as described in Materials and Methods. All stages of neutrophil
maturation (Pr, promyelocyte ; M, myelocyte ; Mm, metamyelocyte; Pm, PMN) demonstrate
evenly dispersed enzyme activity in very small granules (arrows) . This dispersed activity is
more evident when compared with inhibitor-treated (zero activity) cells (c). (b) Beige bone
marrow . Immature neutrophils (promyelocytes [Pr] and myelocytes [M]) have intense reaction
products in giant granules (arrows) . Later stages of neutrophil maturation (metamyelocytes
[Mm] and PMNs [Pm]), however, have completely negative or very weak activity . The
metamyelocyte of this field has very weak activity, most metamyelocytes have substantial
activity (see Table V) . (c and d) Either normal marrow (c) or beige marrow (d) were pretreated
with MeO-Sue-Ala-Ala-Pro-Val-CH 2CI (neutrophil elastase inhibitor) plus Z-Gly-Leu-Phe-
CH2CI (cathepsin G inhibitor) before staining for activity . These treatments resulted in no
detectable activity staining in neutrophils of either normal marrow or beige marrow. x 2,000 .1368
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TABLE III
Percentage ofImmature and Mature Neutrophils and Neutrophil Elastase in Bone Marrow of
Normal (+/+) andBeige(bgJ/bgJ)Mice at Various Times AfterPeritoneal Implantation
of a Copper-rod
Percentimmature neutrophils = 100 X(immatureneutrophils/total marrow cells). Percentmature
neutrophils = 100X (matureneutrophils/total marrow cells). Immature (promyelocyte, myelocyte)
and mature (metamyelocyte, band, PMN) neutrophils were differentiated under the light micro-
scope after Stat staining. Total bone marrow extracts were assayed forelastase activity using the
fluorogenic substrate MeO-Suc-Ala-Ala-Pro-Val-MCA on the indicateddays after implantation of
a copper-rod (see Materials and Methods for detail). Total cells per femur were not different on
the 3 d. Values represent the mean ± SEM.
* P :s 0.005
$P :5 0.001
ip < 0.05
other hand, there was little or no change in elastase-specific activity (U/mg
protein) during this time, despite the fact that the numberofmature neutrophils
was increased in parallel to normal marrow. On day 6, when mature neutrophils
were >10 times greater than immature neutrophils, the elastase activity was
actually reduced in beige mice (Table III).
A third method of testing whether the measured elastase in bone marrow is
bona fide neutrophil elastase is to use inhibitors of elastase activity that are cell
specific. Neutrophils, macrophages and platelets contain elastases of different
substrate and inhibitor specificity. Neutrophil elastase is a serine proteinase (6,
7, 20). Elastase derived from macrophages (21, 22) is a metal-requiring enzyme
and is susceptible to the chelating agent, EDTA, but totally insensitive to serine
proteinase inhibitors such as PMSF. The elastolytic activity in platelets, unlike
neutrophil elastase, is not inhibited by a,-antitrypsin (23).
When bone marrow extracts were pretreated with a series oftypical proteinase
inhibitors (Table IV), the elastase activity was almost completely inhibited by
serine proteinase inhibitors such as PMSF, soybean trypsin inhibitor, and by a,-
antitrypsin, and was weakly inhibited by aprotinin. More importantly, the syn-
thetic peptide chloromethyl ketone MeO-Suc-Ala-Ala-Pro-Val-CH2C1 (24), a
specific neutrophil elastase inhibitor (19, 20, 24), was found to be a potent
inhibitor of bone marrow elastase. In fact, no elastase activity was detected from
bone marrow extracts after treatment with this synthetic peptide. However, full
activity was present with thiol reagents such as N-ethylmaleimide and p-chloro-
mercuribenzoate, and with the chelating agent, EDTA. These results suggest
the absence ofany thiol group(s) in the active site and no metal ion requirement
Exp. Marrow n Day
Neutrophils
Immature Mature
Elastase
U/mg protein Unitsper neu-
trophil X 10
A Normal 5 0 8.8 :t 0.9 40.5 t 1.8 5.25 t 0.23 4.35 t 0.17
5 3 16.3±0.8* 62.2±1 .3$ 8.05±0.711 4.20±0.32
4 6 7.7 ± 2.2 74.1 ± 2.8x 13.00 t 0.78# 6.28 ± 0.531
B Beige 6 0 6.3 ± 1.2 45.6 ± 2.7 2.57 t 0.29 2.54 ± 0.14
5 3 18.6 ± 1.3$ 60.5 t 0.7* 3.29 ± 0.25 2.28 ± 0.27
5 6 3.9 ± 0.5 78 .4 ± 1.0$ 1.84 t 0.07 1.03 ± 0.05$TABLE IV
Effect of Various Reagents on Mouse Bone Marrow Elastase
Bone marrow extracts from normal and beige mice were prepared as
described in Materials and Methods. The extracts were preincubated in
20 mM imidazole-HCI, pH 7.2, containing 0.15 M NaCl, 0.2% Triton X-
100, and 0.2 M sucrose at 25*C for 30 min with the reagents, and
remaining elastase activity was assayed with McO-Suc-Ala-Ala-Pro-Val-
MCA as substrate. The final concentration of inhibitors is indicated in
parentheses and activity ofenzyme is expressedas a percentage of activity
against a control experiment with no inhibitor added set at 100%.
TABLE V
Bone Marrow Enzyme Histochemistry With Naphthol AS-D ChloroacetateActivity Scores
Bone
marrow
TAKEUCHI ET AL.
Reagent
Activity
Activity remaining
Normal Beige
Myeloblasts Promyelocytes Myelocytes Metamyelocytes PMNs
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Normal
￿
1.00 t 0.52 (10)
￿
8.85 t 0.25 (68)
￿
8.24 t 0.07 (127)
￿
8.12 3 0.04 (249)
￿
9.11 t 0.05 (800)
Beige
￿
0.88 t 0.90 (8)
￿
9.28 3 0.11 (74)
￿
9.28 t 0.07 (118)
￿
2.89 t 0.08 (299)*; ￿0 .79 t 0.05 (401)1
Bone marrow smears from four normal and four beige mice were prepared and naphthol AS-D chloroacetate hydrolytic activity was
examined as described in Materials and Methods. The activity score in normal and beige marrow smears was determined
microscopically by identifying neutrophil developmental stages and visually grading the intensity of enzyme stain of each cell from
0 to 4+ (lowest intensity tohighest). Values represent the meanscore t SEM for the numberof neutrophils indicated inparentheses.
* Beige myelocytes vs. Beige metamyelocytes, p <_ 0.01 .
$ Beige metamyelocytes vs. normal metamyelocytes, p <_ 0.025.
f Beige PMNs vs. Normal PMNs, p :5 0.001 .
for activity. The negative inhibition with Z-Gly-Leu-Phe-CI 2C1 shows that activ-
ity is not due to cathepsin G (24). Also, the effects of the inhibitors were
equivalent in both normal and beige marrow suggesting that marrow elastase, as
measured by MeO-Suc-Ala-Ala-Pro-Val-MCA, is predominantly in neutrophils
in both types ofmice.
Neutral Proteinase Activity at Specific Developmental Stages of Marrow Neutro-
phils. The lowered activities ofelastase and cathepsin G in marrow neutrophils
of beige mice prompted us to examine if this loss of activity occurred at a
particular developmental stage(s). Immature neutrophils of beige marrow had
readily visible neutral proteinase activity (Fig. 1 b). The activity was visually
estimated and scored accordingly (Table V). Theactivity scoreinnormal marrow
was quite consistent with the range between 3.11 and 3.35 at all stages of
neutrophil development except for the expected much lower levels at the
myeloblast stage (Table V). Similar activity scores were found in normal and
EDTA (5 mM) 100 100
N-Ethylmaleimide (1 mM) 100 100
Aprotinin (0.1 mM) 98 96
p-Chloromercuribenzoate (1 mM) 92 93
Z-Gly-Leu-Phe-CH2CI (0.1 MM) 91 88
a,-Antitrypsin (0.1 mM) 0 0
MeO-Suc-Ala-Ala-Pro-Val-CH2Cl (0.1 MM) 0 0
PMSF (1 mM) 7 6
Soybean Trypsininhibitor(0.1 mM) 0 01370 ELASTASE AND CATHEPSIN G IN BONE MARROW
TABLE VI
Percent Distribution ofNeutralProteinase Scores in
Bone Marrow PMNs
Score
Percent with corresponding score
Bone marrow smears from normal and beige mice were histochemically
stained for neutral proteinase activity (see Materials and Methods and
Table V for details). Individual PMNs were scored for neutral proteinase
activity as described in Table V. Numbers indicate thepercent of normal
or beige PMNs in each score category. 78 normal PMNs and 124 beige
PMNs were scored. The values in this table are a representative result
from three separate experiments.
TABLE V11
Enzymatic Activities ofBone Marrow Extracts in Normal
and BeigeMice
Bone marrow extracts from C57BL/6J (+/+) and C57BL/6J (bgj /bgJ )
mice were prepared as described in Materials and Methods. Cathepsin D
wasdetermined with hemoglobin as substrate. Collagenase-like peptidase
activity was measured using Suc-Gly-Pro-Leu-Gly-Pro-MCA as substrate.
S-Glucuronidasewas assayed with 4-methylumbellifery-,6-D-glucuronide as
substrate. Plasminogen activator(s) was assayed with t-Boc-Val-Gly-Arg-
MCA as substrate. Activities are expressedas U/mg protein t SEM with
number of samples assayed shown in parentheses. Units of activity were
expressedas described in (7).
beige neutrophils in early development stages including myeloblast, promyelo-
cyte, and myelocyte, although there was a slight (7%) but significant lowering of
activity in beige metamyelocytes. In beige marrow, however, a precipitous
decrease in activity was detected between the metamyelocyte and PMN stages
(Table V). PMNs of beige marrow demonstrated 23% ofthe activity of normal
PMNs (Table V). When the activities ofindividual PMNs ofbeige marrow were
more closely examined (Table VI), it was found that the large majority (86%)
have either undetectable (0) or very low (I+) activity levels. Only a few percent
had the normal activity scores (3+ or 4+) characteristically found in PMNs of
normal marrow.
Other Enzymes in Bone Marrow.
￿
As was found in mature neutrophils (7), three
proteinases, cathepsin D, collagenase-like peptidase, plasminogenactivator(s) and
#-glucuronidase, were not significantly different in normal and beige bone
marrow extracts (Table VII).
Enzyme Normal (+/+) Beige (bgJlbgJ)
Cathepsin D 26.8 t 0.97 (4) 24.4 ± 1.17 (4)
Collagenase-like peptidase 1.35 t 0.11 (4) 1.23 ±0.08 (4)
,B-Glucuronidase 153 ± 5.4 (3) 169 ± 6.2 (5)
Plasminogen activator(s) 1.27 ± 0.14 (4) 1.47 ± 0.05 (5)
Normal Beige
0 1 57
1+ 4 29
2+ 6 10
3+ 9 3
4+ 80 1Beige
Normal
Beige
Normal
Beige
Normal
C57BL/6J (+/+)
￿
3.241 t 0.228 (4)
￿
5.12 t 0.45 (4)
C57BL/6J (bgl/bgl)
￿
0.100 f 0.003 (3)*
￿
0.17 t 0.05 (3)*
Neutrophils (3-5 x 10('/mouse) were isolated from whole blood (see
Materials and Methods). The purity of neutrophils was >99%. Elastase
was assayed with the substrate MeO-Suc-Ala-Ala-Pro-Val-MCAand spe-
cific activity is expressed as mean t SEM of assays of the number of
individual mice in parentheses. Equivalent concentrations of neutrophils
were found in wholeblood of normal and beigemice.
P <_ 0.001
0 1
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TABLE VIII
Blood Neutrophil Elastase ofNormal and Beige Mice
Genotype
￿
Elastase
￿
Cathepsin G
unitsper PMN
Bone
Marrow
Blood
Neutrophils
Peritoneal
Neutrophils
x 107
FIGURE 3. Summary of mouse neutrophil
elastase activity for three neutrophil develop-
mental stages. The results for bone marrow
and blood neutrophils are from this report,
while those for elicited peritoneal neutrophils
were taken from Takeuchi et al. (7). Elastase
activity was assigned with the standard enzyme
assay procedure described in Materials and
Methods.
Elastase and Cathepsin G Activities of Peritoneal and Blood Neutrophils.
￿
To
determine ifcirculating neutrophils (i.e., mature, but recently derived from bone
marrow) have elastase activity, blood neutrophils from normal and beige mice
were purified and examined for elastase and cathepsin Gactivities (Table VIII).
Interestingly, the blood neutrophils of beige mice contained very little elastase
and cathepsin G activities (<4% of normal levels). Therefore, our data suggest
thatelastase and cathepsin G arepresent in immature andmaturing bonemarrow
neutrophils but are nearly completely lost by the time these neutrophils release
intothe circulation(Fig. 3 and TableVIII). The loss inbonemarrow isprincipally
at the mature PMN stage.
Discussion
Fig. 3 summarizes our findings (from this paper and reference 7) on elastase
activity of peritoneal and blood neutrophils and of bone marrow of normal and
beige mice. Our findings have also indicated that cathepsin G follows the same
scheme in its activity. The striking observations are that these activities are
virtually absent in beige blood and peritoneal neutrophils, but are only partially
(40%) lower than that of the C57BL/6J normal mouse in bone marrow. Normal1372
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neutrophils, however, have nearly equal activity in bone marrow, blood, and
peritoneal neutrophils. The elastase and cathepsin G genes are expressed in bone
marrow of beige mice, but there follows an inactivation or loss ofeach in bone
marrow neutrophils mainly at the mature PMN developmental stage (though
some loss is detectable at the metamyelocyte stage) just before their release into
the blood.
The significant levels of elastase and cathepsin G activities in bone marrow
neutrophils ofbeigemiceare important becausethey indicate that themechanism
ofabsence ofneutral proteinase activity in blood and peritoneal neutrophils (7)
is not due to a lack of genetic expression (for example, deleted elastase and
cathepsin G genes, or inability to produce elastase and cathepsin G mRNAs or
active elastase and cathepsin G protein). Instead, the defect likely involves
accelerated degradation or inactivation of the active enzymes. In fact, we have
detected (Takeuchi, K. H., in preparation) increased levels ofelastase inhibitory
activity in extracts ofbeige neutrophils. Rausch etal. (12)havelikewise presented
evidence that elastase and cathepsin G are detectable by immunocytochemical
methods in bone marrow neutrophils of CHS patients. Evidence based on beige
and normal mice with reciprocally transplanted bone marrow (7) indicates that
extrinsic factors in the circulation or other humoral environments of the beige
mouse are not responsible for elastase and cathepsin G inactivation. Rather, the
lowering of elastase and cathepsin G activities in mature beige neutrophils is a
cellular defect.
Three types of experiments suggest that the activities measured in bone
marrow are derived from neutrophils and their precursor cells. First, histochem-
ical enzyme staining in bone marrow indicated that the enzyme is restricted to
neutrophils and neutrophil precursors. Second, when mature neutrophils were
increased in bone marrow by copper-rod implantation in normal mice, a corre-
sponding increase in marrow elastase specific activity occurred. Third, elastase
activity of bone marrow was highly sensitive to inhibitors of neutrophil elastase
(19), but not to inhibitors ofother major elastases such as those of macrophages
and platelets (21-23). The lack ofinhibition by EDTA rules out a contribution
ofthe metalloelastase of macrophages (21, 22). In addition, the complete inhi-
bition of bone marrow elastase by al-antitrypsin (Table IV) strongly indicates
that bone marrow elastase is not the same as platelet-type elastase (23). The weak
inhibition by aprotinin is consistent with the activity being in neutrophils since
others (25) have reported aprotinin has only weak inhibitory activity toward
granulocyte elastase. Thus, the inhibitor evidence shows that bone marrow
elastase is a serine proteinase with characteristics identical to neutrophil elastase
and therefore likely derives from neutrophils and neutrophil progenitors in bone
marrow. Other indirect observations are consistent with a neutrophil source .
First, lymphocytes, another major class of cells present in bone marrow, have
been suggested to have insignificant elastase levels (7) as measured with the
fluorogenic substrate. In fact, lymphocytes, monocytes, and other cells in bone
marrow failed to demonstrate enzyme activity with the histochemical substrate
detection used here. Second, when elastase activity in marrow is calculated on a
per neutrophil basis (Fig. 3), the activity in marrow is nearly identical to that in
blood and peritoneal neutrophils in normal mice, a fact that is consistent with aTAKEUCHI ET AL.
￿
137 3
common cellular origin. Third, elastase activity in a putative minor unidentified
cell type of marrow would have to be remarkably high compared with that
calculated per neutrophil, since neutrophils in the case of mice implanted 6 d
with copper-rod form 80% of total marrow cells.
The lowered activities of elastase and cathepsin G in bone marrow of beige
mice could be due to: (a) a decreased activity in all marrow neutrophil cells at all
stages of marrow development or (b) a preferential inactivation of activity of the
more mature neutrophils. For the first possibility to hold, a precipitous inacti-
vation of elastase and cathepsin G activity would be required upon release of
mature neutrophils since blood neutrophils have only 4% the activity of beige
bone marrow neutrophils. The results of the histochemical tests directly support
the second possibility. It was found that all developmental stages of beige
neutrophils including myeloblast, promyelocyte, myelocyte, and metamyelocyte
have equal activities in normal and beige marrow with the exception of a slight
decrease in beige metamyelocytes. In the myeloblast stage, both normal and
beige indicated very low enzyme staining scores probably because these cells had
just initiated synthesis of azurophilic granule enzymes (10). In contrast, mature
PMNs of beige marrow had only 23% (on average) of the normal activity. Most
PMNs of beige marrow, in fact, had no detectable activity. Thus the inactiva-
tion/loss of neutral proteinase activity in neutrophils of beige marrow occurs at
a specific late point in neutrophil maturation, possibly commencing at the
metamyelocyte stage and reaching completion early in the PMN stage. Mature
PMNs released into the circulation, therefore, have almost no activity. The
second possibility is also indicated by the results of the copper-rod implantation
experiment. It was found that while the percentage of mature neutrophils in
bone marrow increased in beige marrow from ^-45 to 78% after 6 d implantation,
the specific activity of neutrophil elastase per milligram total marrow protein did
not significantly change at 3 d and decreased significantly (-45%) from day 3 to
day 6 (Table III). Also, on a per neutrophil basis the specific activity in beige
marrow decreased from day 0 to day 6 (Table III), consistent with a preferential
loss in activity in mature neutrophils. The elastase activity in bone marrow of
beige mice more closely parallels the change in percentage of immature neutro-
phils. The percentage of immature neutrophils is significantly higher at day 3
than either day 0 or day 6. While elastase activity is not significantly different
between days 0 and 3 in beige marrow, it is significantly lower on both a per
milligram protein and a per neutrophil basis on day 6 . Taken together, these
results suggest a preferential loss of activity in more mature neutrophils of beige
bone marrow, a result in agreement with the direct histochemical tests.
It is interesting that the time of appearance (promyelocyte stage) (10) of giant
granules in beige mice and CHS patients is dissociated by a large time interval
from the time of loss (mature PMN) of elastase and cathepsin G activities.
Therefore, the loss of these enzyme activities (which reside in giant granules) is
not a direct result of the formation of giant granules. Several authors (12, 26,
27) have pointed out that formation of aggregates, curvilinear arrays, and ring-
shaped structures occurs in late stages of neutrophil maturation in bone marrow
of CHS patients and beige mice. It is likewise of interest that the time of loss of
neutral proteinase activity in beige marrow (late metamyelocyte/early PMN1374
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stages) is close to the time oftermination ofmitotic activities (10) in neutrophils.
Another major metabolic change occurring during this time period is a large
reduction in protein synthesis as evidenced by a reduction in morphologically
identifiable endoplasmic reticulum and free ribosomes (28).
The finding of a virtual lack of elastase and cathepsin G in circulating
neutrophils is important in regard to the etiology ofCHS. Since elastase ofCHS
neutrophils is inactivated before their arrival at infection sites, this may explain
their lowered ability to kill invading bacteria (9). Ifbone marrow neutrophils of
CHS patients have, like beige mice, significant elastase and cathepsin Gactivities,
then therapies that prevent inactivation of these enzymes would be clinically
significant. Additionally, it would be of interest to determine elastase and
cathepsin G activities in circulating neutrophils of CHS patients during periods
of peripheral left shift in neutrophil granulocytes as, for example, during mobi-
lization and premature release in response to infections or other leukemoid
reactions (29). The immature neutrophils released from marrow under these
conditions may contain significant neutral proteinase activity.
The absence of elastase and cathepsin G activities in circulating and tissue
neutrophils of beige mice suggests this would provide an interesting model
system to study other physiologically important processes. For example, emphy-
sema has been associated with damage of lung tissue by neutrophil serine
proteinases (19, 30) that are virtuallyabsent (7) in beige mice. The beige mutant,
therefore, potentially could be used to test the involvement ofother factors such
as macrophage elastase in the absence ofneutrophil serine proteinases in emphy-
sema.
Summary
Elicited peritoneal neutrophils ofbeige (Chediak-Higashi) mice essentially lack
activities of the neutral serine proteinases elastase and cathepsin G, which may
explain the increased susceptibility to infection of beige mice and Chediak-
Higashi patients. We have examined neutrophils of beige mice at earlier points
in their development to determine if the proteinase genes are never expressed
or whether they are expressed and then lost during neutrophil maturation.
Surprisingly, bone marrow of beige mice had significant elastase and cathepsin
G activity (^-60% of normal). The results of several experiments indicate that
neutrophils were the sole source of elastase and cathepsin G in bone marrow.
Neutralproteinase activity was readily demonstrable by histochemical procedures
in beige marrow neutrophil precursors up to and including the metamyelocyte
stage. However, mature neutrophils of beige marrow had greatly decreased
activity. Also mature neutrophils (PMNs) of the peripheral circulation, like
peritoneal neutrophils, had very low elastase and cathepsin Gactivities. Thus we
conclude that beige neutrophil precursors express neutral proteinase activity,
which is largely and irreversibly depleted by the time they fully mature in
marrow.
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